These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2888849)

  • 21. Effect of bile on cyclosporin absorption in liver transplant patients.
    Mehta MU; Venkataramanan R; Burckart GJ; Ptachcinski RJ; Delamos B; Stachak S; Van Thiel DH; Iwatsuki S; Starzl TE
    Br J Clin Pharmacol; 1988 May; 25(5):579-84. PubMed ID: 3044424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic evaluation of the blood-to-lymph transfer of cyclosporin A in rats.
    Ueda CT; Lemaire M; Misslin P
    Biopharm Drug Dispos; 1983; 4(1):83-94. PubMed ID: 6839005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of cyclosporin A level for efficacy or renal dysfunction in psoriasis.
    Feutren G; Friend D; Timonen P; Barnes A; Laburte C
    Br J Dermatol; 1990 Jun; 122 Suppl 36():85-93. PubMed ID: 2369572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of sample preparation on concentrations of cyclosporin A measured in plasma.
    Yatscoff RW; Rush DN; Jeffery JR
    Clin Chem; 1984 Nov; 30(11):1812-4. PubMed ID: 6488526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new method for measuring the free fraction of cyclosporin in plasma by equilibrium dialysis.
    Henricsson S
    J Pharm Pharmacol; 1987 May; 39(5):384-5. PubMed ID: 2886587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of nicardipine on renal function and plasma cyclosporin in renal transplant patients.
    Kessler M; Netter P; Renoult E; Jonon B; Mur JM; Trechot P; Dousset B
    Eur J Clin Pharmacol; 1989; 36(6):637-8. PubMed ID: 2673796
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of sample preparation on cyclosporin G (NVA2-cyclosporin) concentration.
    Yatscoff RW; Jeffrey JR
    Clin Chem; 1987 Jul; 33(7):1257. PubMed ID: 3297425
    [No Abstract]   [Full Text] [Related]  

  • 29. Distribution of cyclosporin A metabolites among plasma and cells in whole blood: effect of temperature, hematocrit, and metabolite concentration.
    Lensmeyer GL; Wiebe DA; Carlson IH
    Clin Chem; 1989 Jan; 35(1):56-63. PubMed ID: 2642763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between cyclosporin and erythromycin in a kidney transplant patient.
    Kessler M; Louis J; Renoult E; Vigneron B; Netter P
    Eur J Clin Pharmacol; 1986; 30(5):633-4. PubMed ID: 3530783
    [No Abstract]   [Full Text] [Related]  

  • 31. Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A.
    Hows JM; Chipping PM; Fairhead S; Smith J; Baughan A; Gordon-Smith EC
    Br J Haematol; 1983 May; 54(1):69-78. PubMed ID: 6342656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spiramycin does not increase plasma cyclosporin concentrations in renal transplant patients.
    Kessler M; Netter P; Zerrouki M; Renoult E; Trechot P; Dousset B; Jonon B; Mur JM
    Eur J Clin Pharmacol; 1988; 35(3):331-2. PubMed ID: 3053210
    [No Abstract]   [Full Text] [Related]  

  • 33. Development and validation of a method to determine the unbound paclitaxel fraction in human plasma.
    van den Bongard HJ; Kemper EM; van Tellingen O; Rosing H; Mathôt RA; Schellens JH; Beijnen JH
    Anal Biochem; 2004 Jan; 324(1):11-5. PubMed ID: 14654039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High dose methylprednisolone increases plasma cyclosporin levels in renal transplant recipients.
    Klintmalm G; Säwe J
    Lancet; 1984 Mar; 1(8379):731. PubMed ID: 6143058
    [No Abstract]   [Full Text] [Related]  

  • 35. Application of HPLC with a metal-free column to the analysis of cyclosporin in whole blood samples from cardiac transplant patients.
    Loo JC; Jordan N; McGilveray IJ
    Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):261-4. PubMed ID: 3055108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.
    Atcheson BA; Taylor PJ; Mudge DW; Johnson DW; Hawley CM; Campbell SB; Isbel NM; Pillans PI; Tett SE
    Br J Clin Pharmacol; 2005 Mar; 59(3):271-80. PubMed ID: 15752372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the calculation of the concentration dependence of drug binding to plasma proteins with multiple binding sites of different affinities: determination of the possible variation of the unbound drug fraction and calculation of the number of binding sites of the protein.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Feb; 96(2):249-57. PubMed ID: 17051587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A method for determining the cyclosporin A concentration in capillary blood].
    Obukh IB; Kazarov AR; Filiptsev PIa
    Ter Arkh; 1989; 61(7):82-4. PubMed ID: 2588149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of cyclosporin A between blood cells and plasma of cardiac and renal transplant recipients.
    Hamberger C; Urien S; Barre J; Brandebourger M; Lemaire M; Lang P; Buisson C; Loisance D; Cachera JP; Lagrue G
    Ther Drug Monit; 1988; 10(1):28-33. PubMed ID: 3287706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution and concentration of cyclosporin in human blood.
    Atkinson K; Britton K; Biggs J
    J Clin Pathol; 1984 Oct; 37(10):1167-71. PubMed ID: 6386891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.